demonstrated that metformin induces metabolic reprogramming of hepatic CD8+ T cells, increasing the motility of these tumor‐infiltrating lymphocytes and enhancing antitumor efficacy, concordant with our observation of a positive association between metformin exposure and CD8+ T cell infiltration (Wabitsch et al. 2022). Here, CD8A is linked to neoplasm.